IL323200A - תכשיר למתן דרך הפה מוצק של אולאפריב ומלחים שלו - Google Patents

תכשיר למתן דרך הפה מוצק של אולאפריב ומלחים שלו

Info

Publication number
IL323200A
IL323200A IL323200A IL32320025A IL323200A IL 323200 A IL323200 A IL 323200A IL 323200 A IL323200 A IL 323200A IL 32320025 A IL32320025 A IL 32320025A IL 323200 A IL323200 A IL 323200A
Authority
IL
Israel
Prior art keywords
olaparib
povidone
solid oral
composition
oral composition
Prior art date
Application number
IL323200A
Other languages
English (en)
Inventor
Dharmesh Mahendrabhai Shah
Manappa Badiger Aravind
Abhijeet Upadhye
Samir Panchal
Nishit Gohel
Rutvi G Thakkar
Somnath Wabale
Original Assignee
Bdr Pharmaceuticals International Private Ltd
Dharmesh Mahendrabhai Shah
Manappa Badiger Aravind
Abhijeet Upadhye
Samir Panchal
Nishit Gohel
Rutvi G Thakkar
Somnath Wabale
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bdr Pharmaceuticals International Private Ltd, Dharmesh Mahendrabhai Shah, Manappa Badiger Aravind, Abhijeet Upadhye, Samir Panchal, Nishit Gohel, Rutvi G Thakkar, Somnath Wabale filed Critical Bdr Pharmaceuticals International Private Ltd
Publication of IL323200A publication Critical patent/IL323200A/he

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/50Pyridazines; Hydrogenated pyridazines
    • A61K31/502Pyridazines; Hydrogenated pyridazines ortho- or peri-condensed with carbocyclic ring systems, e.g. cinnoline, phthalazine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2013Organic compounds, e.g. phospholipids, fats
    • A61K9/2018Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2022Organic macromolecular compounds
    • A61K9/2027Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D237/00Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
    • C07D237/26Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings condensed with carbocyclic rings or ring systems
    • C07D237/30Phthalazines
    • C07D237/32Phthalazines with oxygen atoms directly attached to carbon atoms of the nitrogen-containing ring

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Chemistry (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
IL323200A 2023-03-09 2025-09-07 תכשיר למתן דרך הפה מוצק של אולאפריב ומלחים שלו IL323200A (he)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN202321015565 2023-03-09
PCT/IN2024/050241 WO2024184927A1 (en) 2023-03-09 2024-03-09 Solid oral composition of olaparib and its salts thereof

Publications (1)

Publication Number Publication Date
IL323200A true IL323200A (he) 2025-11-01

Family

ID=92674368

Family Applications (1)

Application Number Title Priority Date Filing Date
IL323200A IL323200A (he) 2023-03-09 2025-09-07 תכשיר למתן דרך הפה מוצק של אולאפריב ומלחים שלו

Country Status (6)

Country Link
EP (1) EP4676484A1 (he)
AU (1) AU2024232985A1 (he)
CO (1) CO2025013863A2 (he)
IL (1) IL323200A (he)
MX (1) MX2025010524A (he)
WO (1) WO2024184927A1 (he)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8809349B2 (en) * 2011-01-10 2014-08-19 Infinity Pharmaceuticals, Inc. Processes for preparing isoquinolinones and solid forms of isoquinolinones
CN104434809B (zh) * 2014-12-10 2018-10-16 北京科莱博医药开发有限责任公司 一种奥拉帕尼固体分散体制剂及其制备方法
CN108201536A (zh) * 2016-12-16 2018-06-26 中国科学院上海药物研究所 一种奥拉帕尼口服缓控释药物组合物及其用途

Also Published As

Publication number Publication date
EP4676484A1 (en) 2026-01-14
AU2024232985A1 (en) 2025-10-16
WO2024184927A1 (en) 2024-09-12
CO2025013863A2 (es) 2025-10-20
MX2025010524A (es) 2025-11-03

Similar Documents

Publication Publication Date Title
KR102286501B1 (ko) 레날리도마이드의 경구용 정제 조성물
US12357627B2 (en) Pharmaceutical compositions of cabozantinib
CA3098306C (en) Solid dosage forms with high active agent loading
AU2017262586B2 (en) Improved drug formulations
US20250360085A1 (en) Improved drug formulations
US20220202698A1 (en) Extended release pharmaceutical compositions of riociguat
KR20180097623A (ko) 아프레밀라스트 서방형 제제
EP2701689B1 (en) Pharmaceutical compositions of raltegravir, methods of preparation and use thereof
KR102707060B1 (ko) 안정성 및 생체이용율이 개선된 올라파립 고체 분산체 조성물
EP3210599B1 (en) Gastro-resistant formulation containing posaconazole and a polymeric precipitation inhibitor
WO2021106004A1 (en) Pharmaceutical composition of s-adenosylmethionine
IL323200A (he) תכשיר למתן דרך הפה מוצק של אולאפריב ומלחים שלו
US20080182908A1 (en) Pharmaceutical compositions comprising memantine
US20250025441A1 (en) Pharmaceutical composition and a process to prepare the same
RU2723255C2 (ru) Экструдат с микофенолятом натрия для получения пероральной твердой лекарственной формы
WO2024214120A1 (en) Pharmaceutical compositions of nilotinib
WO2026013152A1 (en) Pharmaceutical composition comprising olaparib
WO2018093289A1 (ru) Пероральная твердая лекарственная форма и способ ее получения